ストックスクリーナーアプリを入手
0.67
6.00%
-0.0428
前日終値:
$0.7128
開ける：
$0.72
24時間の取引高:
156.36K
Relative Volume:
0.46
時価総額：
$97.81M
収益：
$49.09M
当期純損益:
$-52.15M
株価収益率:
-1.0308
EPS:
-0.65
ネットキャッシュフロー:
$-45.93M
1週間 パフォーマンス:
-20.83%
1か月 パフォーマンス:
-17.60%
6か月 パフォーマンス:
-60.82%
1年 パフォーマンス:
-53.15%
1日の値動き範囲:
$0.67
$0.7754
1週間の範囲:
$0.67
$0.8517
52週間の値動き範囲:
$0.67
$2.04
Biodesix Inc Stock (BDSX) Company Profile
BDSX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.67 | 97.81M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-07-26 | 開始されました | Craig Hallum | Buy |
| 2024-05-13 | 開始されました | TD Cowen | Buy |
| 2024-05-03 | 開始されました | Lake Street | Buy |
| 2021-11-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 開始されました | BTIG Research | Buy |
| 2020-11-23 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-23 | 開始されました | Morgan Stanley | Overweight |
| 2020-11-23 | 開始されました | William Blair | Outperform |
すべてを表示
Biodesix Inc (BDSX) 最新ニュース
Perkins Capital Management Inc. Purchases 335,429 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier - Business Wire
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 24.6% in February - Defense World
Biodesix to Present at Cowen’s 42nd Annual Healthcare Conference - Business Wire
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Q1 Earnings Estimate for Biodesix Issued By William Blair - MarketBeat
Biodesix's (BDSX) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
Biodesix (NASDAQ:BDSX) Issues Quarterly Earnings Results - MarketBeat
Q1 Earnings Forecast for Biodesix Issued By William Blair - Defense World
Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Biodesix improved sales, cut losses in fourth quarter, fiscal 2024 - BizWest
Biodesix at TD Cowen Conference: Transformative Year Ahead By Investing.com - Investing.com UK
Biodesix at TD Cowen Conference: Transformative Year Ahead - Investing.com
Analysts Have Been Trimming Their Biodesix, Inc. (NASDAQ:BDSX) Price Target After Its Latest Report - Yahoo Finance
William Blair Estimates Biodesix’s Q1 Earnings (NASDAQ:BDSX) - Defense World
It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - Simply Wall St
Biodesix (NASDAQ:BDSX) Receives “Outperform” Rating from William Blair - Defense World
Biodesix, Inc. Reports Strong Growth Amid Financial Challenges - TipRanks
Positive Outlook for Biodesix: Buy Rating Supported by Salesforce Improvements and Revenue Growth Opportunities - TipRanks
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations By Investing.com - Investing.com South Africa
Observations on the Biodesix Inc (NASDAQ:BDSX) Growth Curve - US Post News
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Biodesix: Strong Growth and Promising Future with Buy Rating from Kyle Mikson CFA - TipRanks
US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says ExpertCrowdStrike Holdings (NASDAQ:CRWD), Biodesix (NASDAQ:BDSX) - Benzinga
Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025 - Insider Monkey
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Biodesix Reports Strong 2024 Financial Performance - TipRanks
Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView
BIODESIX Earnings Results: $BDSX Reports Quarterly Earnings - Nasdaq
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations - Investing.com
Biodesix earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings Flash (BDSX) BIODESIX INC. Reports Q4 Revenue $20.4M, vs. FactSet Est of $19.9M - Marketscreener.com
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewswire
Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock - MSN
Biodesix (BDSX) Expected to Announce Quarterly Earnings on Monday - Defense World
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead O - GuruFocus.com
Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Biodesix (BDSX) to Release Earnings on Monday - MarketBeat
Biodesix to Present at TD Cowen 45th Annual Health Care Conference - The Manila Times
Biodesix Leadership to Share Company Vision at Major Healthcare ConferenceWhat Will They Reveal? - StockTitan
Biodesix Inc (BDSX) 財務データ
収益
当期純利益
現金流量
EPS
Biodesix Inc (BDSX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Pestano Gary Anthony | Chief Development Officer |
Feb 11 '25 |
Sale |
0.92 |
16,748 |
15,479 |
156,008 |
| O'Kane Kieran | Chief Commercial Officer |
Feb 11 '25 |
Sale |
0.92 |
17,527 |
16,198 |
128,039 |
| Hutton Scott | President & CEO |
Feb 11 '25 |
Sale |
0.92 |
83,660 |
77,319 |
701,947 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Feb 11 '25 |
Sale |
0.92 |
24,664 |
22,794 |
246,460 |
0.80%
0.71%
大文字化:
|
ボリューム (24 時間):